Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy for retinoblastoma.

K Akiyama1, M Iwasaki, T Amemiya

  • 1Department of Ophthalmology, Nagasaki University School of Medicine, Japan.

Ophthalmic Paediatrics and Genetics
|June 1, 1989
PubMed
Summary

Chemotherapy shows improved outcomes for bilateral retinoblastoma when initiated within one month of conservative therapy. Unilateral retinoblastoma outcomes were not significantly affected by chemotherapy timing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation.

Diabetes·1997
Same author

Regulation of blood pressure with calcium-dependent dopamine synthesizing system in the brain and its related phenomena.

Brain research. Brain research reviews·1997
Same author

Myocardial infarction and regulatory myosin light chain.

Journal of molecular and cellular cardiology·1997
Same author

[One stage operation for sternal turnover with preserved rectus muscle pedicles and aortic root replacement associated with Marfan's syndrome].

[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai·1997
Same author

Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction.

Circulation·1997
Same author

Temporal pattern of AP-1 DNA-binding activity in the rat hippocampus following a kindled seizure.

Neuroscience·1997

Area of Science:

  • Ophthalmology
  • Pediatric Oncology
  • Medical Research

Background:

  • Retinoblastoma is a pediatric eye cancer requiring effective treatment strategies.
  • Chemotherapy is a common treatment modality for retinoblastoma.
  • Understanding the optimal timing of chemotherapy is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the impact of chemotherapy on retinoblastoma treatment outcomes.
  • To compare outcomes in patients receiving chemotherapy versus those not receiving it.
  • To determine if the timing of chemotherapy initiation affects outcomes in retinoblastoma patients.

Main Methods:

  • A retrospective survey of fourteen retinoblastoma patients treated with chemotherapy.
  • Comparison of patient outcomes with historical data from Japan (1980-1981).
  • Analysis of outcomes based on unilateral vs. bilateral retinoblastoma and chemotherapy timing relative to conservative therapy.

Main Results:

  • No significant difference in outcomes was observed for unilateral retinoblastoma between chemotherapy and non-chemotherapy groups.
  • Bilateral retinoblastoma patients treated with chemotherapy within one month of conservative therapy demonstrated better outcomes.
  • Delayed chemotherapy (more than one month after conservative therapy) was associated with poorer outcomes in bilateral retinoblastoma.

Conclusions:

  • Early initiation of chemotherapy (within one month) is associated with improved outcomes for bilateral retinoblastoma.
  • Chemotherapy timing does not appear to significantly impact outcomes for unilateral retinoblastoma limited to the eyeball.
  • These findings suggest a critical window for chemotherapy intervention in bilateral retinoblastoma management.

Related Experiment Videos